Accessories, reagent kits, consumables, supplies and maintenance agreement for sars-COV-2, HCV, HIV, and HBV PCR testing
Ended Awarded Last action
- Contract number
- 36C26024N0312
- Awardee
-
Abbott Molecular Inc. UEI NK5QDVJBHMN7 Part of Abbott Laboratories
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $238,624
Award facts
- Contract value 100% obligated
- $238,624.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rosemont, IL 60018, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$160,094 | |
| Original award | $398,719 |
About this award
Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a Blanket Purchase Agreement (BPA) call valued at $238,624.26 by Veterans Integrated Service Network 20 (VISN 20) on August 1, 2024, for accessories, reagent kits, consumables, supplies, and maintenance services supporting SARS-CoV-2, hepatitis C virus (HCV), HIV, and hepatitis B virus (HBV) polymerase chain reaction (PCR) testing. The award is a firm fixed-price contract issued under the parent GSA Schedule for In-Vitro Diagnostics, Reagents, and Tests (FSS-65-VII), with performance concluding by July 31, 2025, and fulfillment occurring at Abbott Molecular's Des Plaines, Illinois facility. No small business set-aside designation was utilized in this procurement, consistent with Abbott Molecular's classification as a large, established medical technology corporation.
This contract represents a task order under Abbott Molecular's established blanket purchase agreement portfolio supporting the Veterans Health Administration's diagnostic testing infrastructure. Abbott Molecular maintains multiple IDVs across the VA's Veterans Integrated Service Networks, providing critical molecular diagnostic supplies and reagents for infectious disease screening essential to veteran healthcare delivery. The company's expertise in Alinity M molecular diagnostic analyzer platforms and associated testing reagents for communicable disease detection positions it as a key supplier for the VA's ongoing diagnostic testing requirements across its healthcare system.
Quick answers
Who was awarded contract 36C26024N0312?
36C26024N0312 was awarded to Abbott Molecular Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on August 1, 2024.
How much is contract 36C26024N0312 worth?
The government has obligated $238,624 on 36C26024N0312.
Is contract 36C26024N0312 an order under another contract?
Yes. 36C26024N0312 is a BPA call under V797D40222-36C26021A0063, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C26024N0312 competed?
The extent of competition for 36C26024N0312 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award